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It is well documented that women with robust, Lactobacillus-dominated vaginal 
microbiotas are less likely to develop a range of adverse reproductive health outcomes. 
The birthing process is thought to be a critical event in the initial seeding, or colonization, 
of the human microbiome, and the transfer of microbiota from mother to baby during 
delivery is associated with long-term health. We recruited 88 adult women to a cross-
sectional study to evaluate the relationship between their vaginal microbiota and the 
mode of their birth (self-reported as vaginal delivery or Cesarean section (C-section)). In 
a multivariable analysis, women who had a less protective, low-Lactobacillus community 
state type had 3-fold increased odds of having been born via C-section, indicating that C-
section is related to vaginal dysbiosis in adulthood (adjusted OR: 3.73, p=0.01, 95% CI: 
1.08-12.77). Although the cross-sectional analysis does not account for fluctuations in 
microbial composition, the significant point estimate suggests that birth mode may play a 



















Thesis submitted to the Faculty of the Graduate School of the 
University of Maryland, College Park in partial fulfillment 
of the requirements for the degree of  













Professor Typhanye Dyer, Chair 
Professor Rebecca M. Brotman 




TABLE OF CONTENTS 
Chapter I: Introduction ........................................................................................................ 1 
Literature Review ............................................................................................................ 2 
Research Question and Specific Aims ............................................................................ 7 
Chapter II: Methods .......................................................................................................... 10 
Overview ....................................................................................................................... 10 
Hormonal Contraception Longitudinal (HCL) Study ................................................... 10 
Human Subjects............................................................................................................. 12 
Data Collection .............................................................................................................. 12 
Specimen Collection and Analysis ................................................................................ 14 
Statistical Analysis ........................................................................................................ 16 
Chapter III: Results ........................................................................................................... 18 
Chapter IV: Discussion ..................................................................................................... 31 
Strengths and Limitations.............................................................................................. 33 
Areas for Future Research ............................................................................................. 36 
Appendices ........................................................................................................................ 38 
Appendix A: Institutional Review Board Approval Letters.......................................... 38 
Appendix B: Oral Consent Script ................................................................................. 42 
Appendix C: Telephone Questionnaire ......................................................................... 44 




LIST OF TABLES 
Table 1: Hormonal Contraceptive Longitudinal Study (HCL, parent study) questionnaires 
and selected variables …………………………………………………………...………11 
Table 2: Demographics of birth mode sub-study participants …………………………..23 
Table 3: Crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for 
factors associated with C-section delivery………………………………………………29 
 
LIST OF FIGURES 
Figure 1: Directed acyclic graph with major variables...…………………………………9 
Figure 2: Birth mode study recruitment and participation.………………………………19 





CHAPTER I: INTRODUCTION 
The human microbiome plays an essential role in sustaining health and protecting 
against infections in multiple body sites [1]. The bacteria, archaea, and other eukaryotes 
that compose the microbiome have specific immunologic and homeostatic functions, and 
certain variances or disruptions in the microbiome have been associated with the 
development of diseases such as asthma, autism, and obesity [2-4].  
The birthing process is an early and critical event in the seeding, or colonization, 
of the baby’s microbiome, which can impact child health [5]. The mode of one’s birth 
(i.e., vaginal delivery versus Cesarean section (C-section)) is a key indicator of exposure. 
Neonates born vaginally are exposed primarily to the mother’s vaginal bacterial 
environment and, to a lesser degree, bacteria gained from contact with the mother’s skin 
and other sources. There is strong evidence that babies born vaginally are more likely to 
be colonized by anaerobic bacteria, such as Escherichia coli, Staphylococcus, and 
Streptococcus, which promote a healthy gastrointestinal (GI) environment [6]. However, 
32.0% of U.S. births in 2015 were C-section deliveries [7]. These babies tend to harbor 
bacteria across all body habitats that are more similar to the skin communities of the 
mother [8]. Although research by Azad et al. suggests that these differences in microbial 
composition in the gut due to birth mode can be seen at least 4 months post-delivery, it 
remains unknown how long these characteristics persist past infancy [9]. Studies have 
shown that babies born by C-section are more likely to develop celiac disease, diabetes 
mellitus, and asthma in early childhood [10-12]. These disease outcomes have been 
associated with deviations in the development of the gut microbiota, with observed 
decreases in overall bacterial diversity and abundance of harmful bacterial taxa [13]. 
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These findings indicate that delivery mode and early microbial colonization may not only 
be associated with, but also have a causal relationship, in the development of diseases 
related to dysbiosis of the gut microbiome.   
Despite considerable evidence to suggest the persistent influence of C-section 
delivery on the gut microbiota, there has been little attention given to the effect of birth 
mode on other body sites. In addition, the available research has also been limited to 
outcomes in infants and children. The goal of this thesis is to investigate potential 
associations between a woman’s mode of birth and her vaginal microbiota in adulthood. 
A vaginal microbiota dominant in Lactobacillus spp. is commonly viewed as “optimal,” 
and numerous studies have demonstrated that women with Lactobacillus-dominated 
vaginal microbiota are less likely to develop a range of reproductive health outcomes, 
including bacterial vaginosis (BV), sexually transmitted infections (STIs), and cervical 
cancer [14-16]. As few studies explore how a healthy vaginal microbiome is initially 
colonized, this research will contribute to the understanding of how birth mode relates to 
bacterial composition in adulthood.     
 
LITERATURE REVIEW 
The microbiota in sites throughout the body differ in terms of the types, diversity, 
and relative abundance of the bacteria that are likely to thrive. Certain body sites, such as 
the skin and GI tract, usually benefit from richly diverse bacterial environments. In these 
body habitats, highly-diverse communities tend to be more stable and are associated with 
better health outcomes [17]. In contrast, vaginal communities tend to be more 
homogenous and are usually dominated by one or more species of Lactobacillus [18].  
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Most Lactobacillus spp. are protective for the vaginal environment, primarily by 
producing lactic acid, which lowers the regional pH and acts as an antimicrobial against 
pathogens [19, 20]. Without these Lactobacillus and lactic acid available, women are at 
greater risk for STIs such as gonorrhea, chlamydia, and HIV upon exposure, as well as 
the development of BV [21, 22]. Vaginal Lactobacillus spp. may also help to restrict the 
growth of pathogens by producing bacteriocins (bactericidal proteinaceous molecules) 
[23-27], antagonistic bacteriocin-like substances [28], and biosurfactants [29], and 
through their ability to adhere to mucus, which enable them to form a barrier against 
pathogens [30] and disrupt biofilms [31]. Lactic acid also appears to control overgrowth 
of bacteria by disrupting the integrity of some bacterial cell membranes [32-37]. In 
addition, there is evidence that lactobacilli influence the ability of Trichomonas vaginalis 
to adhere to host cells, thereby altering the virulence of this parasite [38]. Overall, 
Lactobacillus spp. provide multifaceted protection against pathogenic organisms and is 
our outcome of interest. 
Vaginal bacterial communities can be broadly clustered into five groups or 
“community state types” (CSTs) based on their diversity and relative abundance of 
bacteria [18]. Four CSTs are dominated by Lactobacillus, L. crispatus (CST I), L. gasseri 
(CST II), L. iners (CST III), or L. jensenii (CST V). We hypothesize that there are 
functional differences among these species. In one study of adult women by Verstraelen 
et al., L. crispatus-dominated profiles promoted the stability of the normal vaginal 
environment, and L. iners and L. gasseri were more highly associated with prevalence of 
dysbiotic, or unbalanced, vaginal microbiota [39]. Gajer and Brotman et al. also found 
that L. iners-dominated CST III was associated with both stable and fluctuating patterns 
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in and out of BV-associated states, but L. gasseri-dominated profiles were remarkably 
stable [40]. CST IV is unique in that it is a low-Lactobacillus state which is characterized 
by the abundance of BV-associated anaerobic organisms, including Gardnerella, 
Megasphera, Sneathia, and Prevotella. Yeoman et al. have hypothesized that several of 
the taxa found in abundance in CST IV may contribute to vaginal dysbiosis and BV by 
producing biogenic amines [41].  
There is little data on how the vaginal microbiome is initially seeded. The 
establishment of stable vaginal microbial communities may rely on several early 
environmental factors. Following a vaginal birth, a neonate is covered in the vaginal 
bacteria from the mother, which have been shown to have an immediate effect on the 
short-term colonization outcomes at several body sites [5]. However, babies born by 
Cesarean delivery do not transit through the environment of protective vaginal bacteria. 
Babies born via C-section have an increased risk of childhood-onset type 1 diabetes and 
obesity at age 3 years, outcomes that may be related to dysbiosis in the microbiota of the 
GI tract [42, 43]. Longitudinal studies investigating the effect of birth mode and neonatal 
exposures have followed infants for 2 years or less. For example, Chu et al. described a 
cohort study of 81 mother and infant dyads in which multiple body sites, including stool, 
oral gingiva, nares, skin and vagina, were sampled for 6 weeks [44]. They observed 
minor variations in the neonates’ microbiota community structure associated with C-
section delivery in most body sites immediately after birth. However, while the infants’ 
microbiota changed significantly at each body site, they reported no discernable 
differences in community structure or function between infants delivered vaginally or C-
section at 6 weeks of age. This study did not collect infant vaginal samples to determine 
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how the vaginal microbiota undergoes reorganization in early life, which underscores the 
need for longitudinal studies assessing the seeding of bacteria in the vaginal environment.  
After infancy, the vaginal microbiome undergoes significant transitions. In early 
childhood, girls tend to be colonized by stable aerobic, anaerobic, and enteric bacteria 
[45]. Important findings by Hickey et al. suggest that the vaginal microbiota of girls 
begins to resemble those of adults (typically dominated by Lactobacillus spp.) before 
menarche, while girls are still in the early and middle stages of puberty [46]. It is thought 
that the composition and function of the vaginal microbiota changes in puberty due to 
increased estrogen-stimulated glycogen production in the vaginal epithelium [47]. 
However, it remains unclear how girls transition and colonize adult-like vaginal 
microbiota, and further studies are needed to explore the influence of genetic and 
environmental factors. This thesis will help address this knowledge gap by investigating 
the environmental exposures caused by a woman’s mode of birth and her bacterial 
colonization in adulthood.     
Although the first menstrual period (menarche) signals the possibility of fertility, 
it is accompanied by several physiological and anatomic changes, which may impact the 
vaginal microbiome. Factors associated with early menarche include levels of 
subcutaneous fat levels, BMI, and being formula fed as an infant [48]. The mean age at 
menarche in the United States is approximately 12.5 years, according to studies 
conducted in 1994 [49, 50]. These sources also indicate a decrease of about 2 to 4 months 
in the average age since the 1970s. Black and Hispanic women tend to have a lower 
average age at menarche compared to White and Asian women, and higher relative 
weight in adolescence is associated with increased likelihood of early menarche [50]. 
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Early age at menarche (younger than 11) is a critical outcome to study because it has 
been found to be a risk factor for asthma, insulin resistance, total number of metabolic 
syndrome components, and increased cardiovascular risk in adulthood [51-53].  
Once an adult-like vaginal microbiota is established, a woman’s CST can 
fluctuate over time due primarily to menstrual bleeding and changes in estrogen and 
progesterone levels [54]. Further, race/ethnicity, age, body mass index (BMI), hygiene 
practices, and sexual behavior are all associated with variances in the microbiota [1, 18, 
55, 56]. Among these risk factors, race/ethnicity is most strongly linked with elevated 
vaginal pH and microbial composition, with Hispanic and African American women 
more likely to have low-Lactobacillus microbiota compared to Caucasian and Asian 
women [14]. Studies of the vaginal microbiome must take host intrinsic and extrinsic 
factors into account as they play a role in microbial composition and disease outcomes.  
The dysbiosis in the vaginal microbiome, and its clinical syndrome bacterial 
vaginosis, have long been considered a nuisance factor in women’s health research. There 
is overwhelming data that disruptions in the vaginal microbiota lead to a wide range of 
adverse outcomes related to women’s health. Current efforts are focused on development 
of new therapies to restore vaginal health. Antibiotics such as metronidazole and 
clindamycin are the current standard for treating BV [57]. Pre- and probiotics have been 
suggested (inconclusively) to promote dominance by Lactobacillus spp. that will help 
stabilize the vaginal microbiota as well as fend off infection by sexually transmitted 
pathogens and importantly, could be antibiotic-sparing [58, 59]. Another preventive 
strategy may be to ensure that newborns are exposed to beneficial microbes at birth. The 
intention of “seeding” a C-section infant is to transfer microbes from the mother that the 
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infant would normally have obtained during vaginal birth. In a recently published pilot 
study, Dominguez-Bello and colleagues found that C-section infants who were seeded 
with vaginal secretions from their mother had gut, oral, and skin bacterial communities 
enriched in vaginal bacteria after 30 days, similar to infants born vaginally [60]. There is 
still controversy surrounding this practice, including transfer of pathogens such as herpes 
simplex virus, and the long-term risks and benefits are unknown. There is no evidence 
currently available from longitudinal studies showing C-section birth as being a risk 
factor for developing vaginal dysbiosis and related diseases at reproductive age. Although 
the enclosed thesis is cross-sectional and cannot account for transitions in the microbiome 
over the life span, it provides the impetus for further study and importantly, presents 
preliminary data in describing the relationship exposure to vaginal microbes at birth to 
vaginal health in adult women.   
 
RESEARCH QUESTION AND SPECIFIC AIMS 
The overall goal of this research is to determine whether the mode of birth is 
associated with vaginal microbiota composition in adulthood. I hypothesize that women 
born by C-section will be more likely to lack the protective vaginal Lactobacillus spp. or 
to be in a somewhat unbalanced (quasi-dysbiotic) state defined by predominance of L. 
iners. Numerous studies have documented that a low-Lactobacillus state creates a 
microenvironment in which women are more susceptible to STIs and urinary tract 
infections [61-63]. This research attempts to uncover birth mode as a risk factor for these 
adverse outcomes. The directed acyclic graph (DAG) in Figure 1 illustrates the interplay 
among the variables identified in the specific aims.  
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SPECIFIC AIM 1: To measure the association between birth mode and the presence of 
protective vaginal microbiota in adult women.  
HYPOTHESIS: Women with a dysbiotic vaginal microbiota defined by low-
Lactobacillus (CST IV) as well as L. iners-dominated (CST III) community 
profiles will be more likely to have been born via C-section. In contrast, women 
with more protective CSTs (dominated by L. crispatus (CST I), L. jensenni (CST 
II), or L. gasseri (CST V)) will be more likely to have been born via vaginal 
delivery.  
SPECIFIC AIM 2: To determine if the associations between birth mode and vaginal 
microbiota are modified by race/ethnicity, a major intrinsic factor known to be associated 
with disparities in the vaginal microbial composition and in C-section rates. 
HYPOTHESIS: The magnitude of the association between birth mode and 
microbiota composition (CST) in adulthood will differ among racial groups. 
SPECIFIC AIM 3: To test for confounding in the association between birth mode and 
vaginal microbiota by age and weight at menarche.  
HYPOTHESIS: Younger age at menarche, as well as higher perceived weight 
status during adolescence, will be associated with C-section delivery and low-







Figure 1: Directed acyclic graph with major variables  
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CHAPTER II: METHODS 
OVERVIEW 
The proposed cross-sectional study involved a cohort of reproductive-age women 
who were enrolled in the Hormonal Contraception Longitudinal (HCL) Study (described 
in detail in the following section). In addition to a secondary analysis of HCL Study data, 
primary data obtained in this study included birth mode and early childhood factors.  
 
HORMONAL CONTRACEPTION LONGITUDINAL (HCL) STUDY 
Conducted by Johns Hopkins School of Medicine researchers (PI: Khalil 
Ghanem, MD, PhD), the HCL Study (NIAID R01-AI089878) aims to describe how the 
initiation or cessation of hormonal contraceptives (HCs), including oral contraceptive 
pills, vaginal rings, etonogestrel contraceptive implants, and other methods, affect the 
vaginal microbiota and immune response in the lower genital tract.  
The HCL Study recruited women ages 16 to 35 years old who planned to start or 
cease using HCs during the study. Controls were women who were not using a HC 
method. Eligibility criteria included not currently being pregnant, having a uterus (not 
post-hysterectomy), and not having any implanted uterine devices (such as Mirena or 
Paraguard). In addition, women diagnosed with illnesses that alter their immune system 
or hormone levels or who take medications that cause changes in their immune system or 
hormone levels were not eligible. Between 2011 and 2016, the HCL Study enrolled 125 
women in the Baltimore, Maryland area. 
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In 8 study visits over 2 years, participants provided blood and urine samples, 
completed medical history and behavior questionnaires, and collected cervical and 
vaginal swabs. Visits were scheduled at baseline, 2 and 4 weeks, 3, 6, 12, 18, and 24 
months. In addition, participants self-collected mid-vaginal swabs twice-weekly 
in the two weeks prior to each visit. HCL participants submitted over 4,500 vaginal 
samples. Collaborators at the University of Maryland School of Medicine Institute for 
Genome Sciences (UMSOM IGS, Brotman laboratory) analyzed these samples by 16S 
rRNA gene amplicon sequencing, and the data were merged with responses to the 
comprehensive reproductive health surveys. 
The specific variables obtained in the Parent study questionnaires and clinical 
exams that were used in the current analysis were chosen based on literature reviews. A 
list of these variables and the HCL questionnaires that were obtained are included in 
Table 1. 
Table 1: Hormonal Contraceptive Longitudinal Study (HCL, parent study)  
questionnaires and selected variables 
Questionnaire Name Selected Variables Included 
Demographics Age, race/ethnicity, education, household income, 
income sources, and marital status 
Health and Medical 
History 
Antibiotic use 
Oral Health and Activity Cigarette smoking 
Reproductive Health and 
Activity 
Self-reported BV diagnosis, douching, lubricant use, 
sexual partners, hormonal contraceptive use, menstrual 
sanitary and feminine hygiene product use 
Clinical Evaluation Height, weight, Amsel criteria for the diagnosis of BV 
(pH, discharge consistency, presence of clue cells, whiff 






Prior to conducting this research, I completed the online Collaborative 
Institutional Training Initiative (CITI) human participants online training program as well 
as HIPAA training 125/201. Our team received Human Subjects Research approval from 
the Institutional Review Boards (IRBs) from University of Maryland, College Park 
(999286-1) and Baltimore (HP-00073692). In addition, Dr. Ghanem received IRB 
approval from the Johns Hopkins University IRB (NA_00043112/CIR00024424) to 
transfer contact information of former HCL participants. All IRB approval letters are 
included in Appendix A. The research team affirmed that participant confidentiality and 
privacy would be maintained.  
 
DATA COLLECTION 
After receiving IRB approval from all sites, HCL study staff transmitted contact 
information of participants who agreed to future contact. As part of the HCL Study 
informed consent and privacy authorization process, participants could decline consent 
for participation in future research studies. Only four members (3.2%) of the original 
cohort did not consent to be contacted by future researchers. I did not receive contact 
information for these women. For the remaining 121 participants, I received protected 
health information (PHI), including participant email addresses, phone numbers, and 
mailing addresses, as well as the link between the subjects’ identification numbers and 
corresponding PHI. I was the only member of the team who had access to the PHI and 
stored this information in a password-protected laptop. The rest of the research team 
received de-identified data. 
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Over 4 weeks, former participants were contacted by phone and email. In cases 
where initial contact was made via email, I made arrangements to call the participant at a 
convenient time. Verbal informed consent was obtained from participants specifically for 
the current research (see oral consent form in Appendix B). They had the opportunity to 
ask questions and decline at any time. At the time of re-contact for the birth mode study, 
all participants were 18 years old or older. None of the women seemed unable to render 
informed consent.   
After consent was received, I administered the 3-item questionnaire (Appendix 
C), in which participants self-reported their birth mode, age at first menstrual period, and 
perceived weight status at menarche. Three women seemed unsure about their answers 
initially, particularly their age at menarche, and took the opportunity to contact their 
mothers to confirm. I received confirmation from all of these women, and only one 
changed an answer she had previously given. Overall, participants were very confident in 
reporting their birth mode responses. Participants were informed that they would receive 
a check for $10 as compensation for their time. At the end of the calls, participants 
verified their current mailing addresses to receive the check. In several cases, women also 
informed me that their last names had changed. The call, including describing the study, 
obtaining consent, administering the survey, and confirming the current mailing address, 
took an average of 7 minutes. 
While most women completed the survey via phone interview, six participants 
asked to receive the questionnaire online, instead. They cited privacy and lack of time to 
complete the call as reasons why they preferred the online version. The text of the online 
survey programmed in REDCap is identical to the script used in phone interviews. A 
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final screen in the online survey allowed participants to enter their full name and current 
address. REDCap was used to store the database with all responses to this survey, 
including those obtained via phone interview.  
Our team has completed data collection for this project, and we will return the 
PHI file with annotations regarding disconnected phone numbers and email addresses to 
the researchers at Johns Hopkins. All copies of the PHI file retained at IGS will be 
deleted.   
 
SPECIMEN COLLECTION AND ANALYSIS 
 This analysis relies on vaginal specimens previously collected by the HCL study 
researchers. While many members of the cohort gave vaginal swabs repeatedly over two 
years, this cross-sectional study will focus on a vaginal swab collected for each 
participant by a study clinician at the enrollment visit (baseline).  
 At IGS, processing of vaginal swabs included the extraction of bacterial DNA, 
polymerase chain reaction (PCR) amplification, and 16S rRNA gene amplicon 
sequencing of the V3-V4 hypervariable regions. Ravel and IGS collaborators developed 
protocols for DNA extraction and bacterial sequencing, which are described in more 
detail in published articles [18, 64]. PCR amplification was performed using dual 
barcoded primers targeting the 338F to 806R region and sequenced on the Illumina 
HiSeq platform. Pre-processing of sequencing reads included assembly of forward and 
reverse reads and the removal of chimeric sequences. Species-level taxonomic 
assignments of each sequence read were performed using a classifier algorithm called 
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Support Vector Machine, which was trained on over 4000 specimens.  For each sample, 
vectors of phylotype proportions were clustered into CSTs using this algorithm. Initial 
sequencing work for these study samples was completed in August 2016. However, the 
IGS groups plans to release new classification data for HCL using a newly-developed 
classifier algorithm, PECAN, later this year [65]. 
 In early analysis of the HCL sequences, seven CSTs were identified. As 
previously described, CSTs I, II, and V indicate dominance by Lactobacillus crispatus, L. 
gasseri, and L. jensenii, respectively. Based on previous findings related to pH and Gram 
staining, these CSTs are characterized as “healthy” or promoting stability of the 
microbiota [40]. The sequenced dataset included designations for CSTs III-A and III-B, 
both dominated by L. iners. The distinction between the sub-types are based on the other 
bacterial taxa found in the samples; CST III-B tends to have a more diverse assemblage 
of BV-associated anaerobes (G. vaginalis) and lower relative abundance of L. iners 
compared to III-A, which is dominated by L. iners and not BV-associated bacteria. 
Preliminary and unpublished research conducted by Ravel and colleagues suggests that 
CST III-B more strongly resembles the diversity of bacteria found in CST IV and 
consequently may be more highly associated with vaginal dysbiosis and BV. CST IV was 
also divided, where IV-A is characterized by anaerobic bacteria including Anaerococcus 
and Prevotella spp., and IV-B contains higher proportions of Gardnerella, Atopobium 
and Megasphaera. This analysis includes a model that combines both CST III sub-types 
with CST IV in the dysbiotic group and a separate model that clusters CST III-A with the 
other Lactobacillus-dominated groups (CSTs I, II, and V) and only includes CST III-B 
and CST IV in the dysbiotic group.  
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  We discovered that two participants, E020 and E082, submitted baseline vaginal 
samples that had less than 2,700 bacterial reads and were classified as CST I. In 
reviewing their subsequent samples submitted at least twice per week for 3 months, their 
samples were consistently classified as CST IV for E020 and CST III for E082 with 
much higher total bacterial reads. The enrollment sample for these participants was 
dropped from the analysis and replaced with a vaginal sample collected 2 days later, 
which in both cases had a sufficient number of bacterial reads such that it could be used 
for analysis. 
STATISTICAL ANALYSIS 
Data analysis involved modeling using STATA 10.0 for Windows (Stata 
Corporation, College Station, Texas) and SAS 9.13 (SAS Institute, Cary, NC). 
Descriptive analyses of the analytic sample were reported for key demographic variables. 
For each categorical demographic variable, a Fisher’s exact test was used to test the 
association with birth mode because there were factors that had a few observations in 
each stratum.  
Aim 1 tested the association between vaginal microbial composition and birth 
mode in this sample. Logistic regression was used to estimate odds ratios (ORs) with 
95% confidence intervals (CIs) for several models. To compensate for the small sample 
size and limited power, we created binary variables from variables of interest. For 
instance, the CST variable was made binary by grouping Lactobacillus-dominant (CSTs 
I, II, III, and V) types in contrast with Lactobacillus-diminished CST IV. Other binary 
categorizations of CST were also explored, including CST III and IV sub-types. In 
addition, we created a dummy variable for race grouping African American and Hispanic 
17 
 
(AAH) women separately, due to low Latina representation in the sample as well as 
support in the literature for similar microbiota outcomes between the two racial/ethnic 
categories [18]. We included unadjusted models and considered models adjusted for 
confounding factors, including douching and education.  
For Aim 2, we tested for effect modification by race/ethnicity in the association 
between birth mode and CST. Again, race/ethnicity was collapsed into a binary variable 
contrasting AAH and non-AAH women. We used a stratified regression approach and an 
interaction term approach to investigate potential effect modification [66]. Aim 3 dealt 
with the role of childhood factors—age and weight status at menarche—in the model. 
Both variables were evaluated as potential confounders, and models with adjustment for 
these childhood factors were compared to models with adjusted for douching status and 
education. 
To visualize differences in the bacterial communities between women born 
vaginally and via C-section, we developed a heatmap in R (R Foundation for Statistical 
Computing, Vienna, Austria). The heatmap included the 25 most abundant bacterial taxa 
found in the samples and were color-coded based on the percent abundance of each 





CHAPTER III: RESULTS 
We recruited 88 women to answer our questionnaire, equaling 70.4% of the full 
HCL cohort and 72.7% of the participants who consented to future contact (Figure 2). 
Roughly 18% (n=16) of these women were born via C-section. The mean age of the study 
participants at HCL study enrollment was 26.2 (SD: 4.4; range: 17.4-34.6). Women were 
interviewed for the birth mode sub-study between 1 and 6 years after their enrollment in 
the parent study. The women represented seven self-reported racial/ethnic groups: 
Asian/Pacific Islander (n=2), Black/African American (n=29), Hispanic/Latina (n=1), 
Native American (n=1), White/Caucasian (n=48), mixed race (n=5), and other (n=2). The 
average age at first menstrual period was 12.0 (SD: 1.76; range 8-17). Most women 
responded that they were average weight at menarche (n=63, 71.6%). Approximately 9% 
responded that they were some degree of underweight (n=8) and over 18% were some 
degree of overweight (n=16) at the time of menarche. The majority of participants (56%) 
provided vaginal samples characterized as CSTs I (n=43), II (n=1), and V (n=5), which 
indicate dominance by L. crispatus, L. gasseri, and L. jensenni, respectively. Several 
participants’ (25%) vaginal microbiota were classified as III-A (n=10) or III-B (n=12), 
indicating dominance by L. iners. Finally, approximately 19% of participants had vaginal 
microbiota with low abundance of Lactobacillus spp. and were classified as IV-A (n=7) 
or IV-B (n=10).  
The heatmap in Figure 3 describes the bacterial community composition of the 
vaginal microbiota of the study population. The data are sorted first by the birth mode of 
the participant and then by CST. Each column represents the vaginal microbiota sampled 
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from a woman at a single time point. The proportions of the 21 most abundant bacterial 
taxa within each sample are indicated by the legend in the top left.  
 
 
Figure 2: Birth mode study recruitment and participation 
Table 2 outlines the demographics of the population tabulated by mode of birth. 
The groups born via C-section and vaginal delivery were similar demographically; 
Fisher’s exact tests for most demographic factors yielded statistically insignificant 
differences. However, women born via C-section appeared more likely to be CST IV, as 
opposed to CST I, II, III, and V (p=.01). There were some moderately significant 
findings, such as a trend indicating that women born via C-section had more years of 
education (p=0.15).  In addition, C-section-born women were more likely to report a 
younger age at menarche (p=0.15), past douching (p=0.08), and tampon use at last 
menstrual period (0.11). The women who reported douching were more likely to be AAH 
HCL Cohort
n=125

















compared to other races (p<0.01). Of the three women who were clinically diagnosed 
with BV at baseline, two were CST IV, and one was categorized to CST III.  
The results of several adjusted and unadjusted models for factors associated with 
C-section delivery are outlined in Table 3. Confounding factors included in the final 
adjusted models were past douching and education, covariates that were found via 
Fisher’s exact tests to be moderately associated with birth mode and CST. Overall, CST 
was significantly associated with birth mode, based on univariable and multivariable 
logistic regression modeling. Model 1 analyzed CST as a binary variable contrasting 
Lactobacillus-dominated vs. Lactobacillus-deficient types and measured its association 
with the C-section outcome. Logistic regression indicated that women with a 
Lactobacillus-deficient CST IV were three times as likely to have a history of C-section 
(crude OR= 4.82, p=0.01, 95% CI: 1.46-15.88; adjusted OR= 3.73 (p=0.01, 95% CI: 
1.08-12.77). In Model 2, vaginal microbiota was clustered into 3 broad groups. CSTs II, 
and V were included in the reference group with CST I, due to low representation of L. 
gasseri- and L. jensenii-dominant participants, and CSTs III and IV were analyzed 
separately. In this model, CST III was not associated with significantly increased odds of 
C-section history (adjusted OR=1.10, p=0.91, 95% CI: 0.29-5.30); however, CST IV 
maintained its significant association with C-section history compared to the reference 
group (OR=3.84, p=0.04, 95% CI: 4.01-14.56). BMI, race/ethnicity, age at menarche, BV 
diagnosis, perceived weight at menarche, and pH were found not to be associated with 
birth mode.    
Based on two analytic approaches for determining effect modification 
(stratification and modeling with effect modification), there was some evidence (though 
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not overall statistically significant) that race modifies the relationship between vaginal 
CST and birth mode. All models grouped African American and Hispanic women (AAH) 
in contrast with other racial/ethnic groups. The results of the regression analyses stratified 
by race suggested that AAH who were CST IV were 8-fold more likely to have a C-
section history (OR=8.89, p=.02) and among non-AAH women who were CST IV, the 
OR was 3-fold (OR=3.00, p=.18). However, a large p-value for the Breslow-Day test 
(0.393) indicated no significant difference in the odds ratios for the two racial/ethnic 
categories. Furthermore, a regression model with an interaction term for race and CST 
revealed a p-value which was not statistically significant (p=0.27). 
To determine whether age and weight status at menarche had a profound 
confounding effect on the relationship between CST and birth mode, we adjusted Model 
1 (which contrasted Lactobacillus-dominated vs Lactobacillus-deficient CSTs) by each 
of these puberty factors. After adjustment for age at menarche (as a continuous variable), 
women with Lactobacillus-deficient microbiota had a 4-fold increased likelihood of C-
section history (OR=4.75, p=0.01, 95% CI: 1.44-15.65). Adjustment for self-reported 
weight status at menarche grouped as normal to underweight versus overweight and 
markedly overweight generated an OR of 4.82 (p=0.01, 95% CI: 1.463-15.89). Both 
adjusted models produced a change in the crude OR that was less than 10%, leading us to 
conclude that these puberty factors do not have a significant confounding effect on the 












Table 2. Characteristics of birth mode sub-study participants (n=88). 
    C-Section (n=16)   Vaginal (n=72)   










Race/ethnicity           0.39 
 Asian/ Pacific Islander 0 0.0   2 2.8   
 Black/ African American 6 37.5   23 31.9   
 Hispanic/ Latina 1 6.3   0 0.0   
 White 8 50.0   40 55.6   
         Other 1 6.3   7 9.7   
            0.27 
         Black or Latina 9 56.3   49 68.1   
         non-Black and non-Latina 7 43.8   23 31.9   
Age at HCL parent study entry           0.44 
17 to 23 7 43.8   27 37.5   
24 to 30 8 50.0   30 41.7   
31 & over 1 6.3   15 20.8   
BMI a           0.14 
<24.9 9 56.3   33 45.8   
24.9-29.9 0 0.0   14 19.4   
>29.9 7 43.8   25 43.8   
            0.32 
<24.9 9 56.3   33 45.8   
>24.9 7 43.8   39 54.2   
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Table 2. Characteristics of birth mode sub-study participants (n=88). 
    C-Section (n=16)   Vaginal (n=72)   
    n %   n % p-value* 
       
Education           0.15 
up to high school 0 0.0   9 12.5   
some college and above 16 100.0   63 87.5   
Income           0.52 
less than $3000 per month 10 62.5   40 55.6   
$3001 or more per month 5 31.3   18 25.0   
no answer  1 6.3   14 19.4   
Income source           0.44 
job 9 56.3   40 55.6   
significant other, family, or friends 0 0.0   9 12.5   
government assistance 1 6.3   3 4.2   
multiple 6 37.5   20 27.8   
Marital Status           0.23 
Never married 11 68.8   61 84.7  
Married 4 25.0   7 9.7   
Divorced 1 6.3   2 2.8   
Other 0 0.0   2 2.8   
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Table 2. Characteristics of birth mode sub-study participants (n=88). 
    C-Section (n=16)   Vaginal (n=72)   
    n %   n % p-value* 



















CST           0.12 
I  (L. crispatus-dominated) 6 37.5   37 51.4   
II  (L. gasseri-dominated) 0 0.0   1 1.4   
III  (L. iners-dominated) 3 18.8   19 26.4   
IV  (Low-Lactobacillus) 7 43.8   10 13.9   
V (L. jensenni-dominated) 0 0.0   5 6.9   
            0.09 
CST I, II, V 6 37.5   43 59.7   
CST III, IV 10 62.5   29 40.3   
            0.01 
CST I, II, III, V 9 56.3   62 86.1   
CST IV 7 43.8   10 13.9   
BV diagnosed within 2 months**           0.45 
no BV  15 93.7   70 97.2   
BV  1 6.2   2 2.8   
Vaginal pH            0.40 
4.0-4.5 10 62.5   51 73.9   
4.6-5.0 2 12.5   10 14.5   
>5.0 4 25.0   8 11.6   
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Table 2. Characteristics of birth mode sub-study participants (n=88). 
    C-Section (n=16)   Vaginal (n=72)   
    n %   n % p-value* 
Vaginal pH (continued)            0.27 
4.0-4.5 10 62.5   51 73.9   
>4.5 6 37.5   18 26.9   
  Vaginal signs (self-reported at clinical 
visit)             
  Discharge 1 6.3   2 2.8 0.46 
  Itching 1 6.3   0 0.0 0.18 
 Ever been pregnant      0.61 
 no  10 62.5  45 62.5  
 yes 6 37.5  27 37.5  
 Ever given birth vaginally      0.58 
 no 13 81.3  57 79.2  
 yes 3 18.8  15 20.8  
 Ever given birth by C-section      0.52 
 no 14 87.5  65 90.3  
 yes 2 12.5  7 9.7  
 Years since last pregnancy      0.51 
 none 11 68.8  45 62.5  
 1 2 12.5  5 6.9  
 2+ 3 18.75  22 30.6  
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Table 2. Characteristics of birth mode sub-study participants (n=88). 
    C-Section (n=16)   Vaginal (n=72)   






Age at menarche           0.17 
≤11 6 42.9   30 41.7   
12 6 37.5   11 15.3   
13 1 6.3   17 23.6   
≥14 3 18.8   14 19.4   
            0.15 
≤12 12 75.0   41 56.9   
>12 4 25.0   31 43.1   
Weight status at menarche a           0.61 
Average or below 13 81.3   58 81.7   





















Hormonal contraceptive use (current)           0.43 
no 9 56.3  36 50.0  
yes 7 43.8  36 50.0  
Number of sexual partners in the prior 2 
months b           0.24 
None 4 28.6   5 8.6   
1 10 71.4   51 87.9   
2+ 0 0.0   2 3.5   
            0.20 
none 4 25.0   10 14.3   
1+ 12 75.0   60 85.7   
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Table 2. Characteristics of birth mode sub-study participants (n=88). 
    C-Section (n=16)   Vaginal (n=72)   
    n %   n % p-value* 
Douched (ever)            0.08 
no 9 56.3   56 77.8   
yes 7 43.8   16 22.2   
Hygiene product use (2 months)             
            Feminine towelette 1 7.1  6 10.0 0.60 
Hygiene spray 0 0.0  3 5.0 0.53 
Hygiene powder 1 7.1  2 3.3 0.47 
            Vaginal acid gel 1 7.1  0 0.0 0.18 
Sanitary product use at last menstrual 
period      0.23 
Tampon only 6 37.5  29 40.3  
Sanitary napkin only  1 6.3  17 23.6  









Antibiotic use***           0.62 
no 14 87.5   62 86.1   
yes 2 12.5   10 13.9   
Smoking            0.45 
no 14 87.5   66 91.7   
yes 2 14.3   6 8.3   
 *Reported p-values from Fisher's exact tests 
**Includes clinician- and self-reported diagnoses  
***Includes antibiotics used 2 months prior to 
 (NOT prescribed at) enrollment visit  
a Missing for 1 respondent   
b Missing for 2 respondents   




Table 3. Crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for factors associated with C-section 
delivery (n=88). 
  Unadjusted   Adjusted* 
  OR 95% CI 
p-
value   OR 95% CI 
p-
value 
  CST               
Model 1           I, II, III, V               (n=71) REF       REF     
           IV                            (n=17) 4.82 1.46-15.89 0.01   3.73 1.08-12.77 0.01 
  CST               
 Model 2  I, II, V                     (n=49) REF       REF     
    III                            (n=22) 1.13 0.26-5.01 0.87   1.10 0.29-5.30  0.91 
      IV                            (n=17) 5.02 1.38-18.21 0.01   3.84 4.01-14.56  0.04 
  BMI                
Model 3 <24.9                       (n=42) REF       REF     
  >=24.9                     (n=46) 0.66 0.22-1.96 0.45   0.57 0.08-1.35 0.12 
  Race               
Model 4 All other races         (n=58) REF     REF   
  Black and Hispanic (n=30) 1.66 0.55-5.00 0.37   1.50 0.44-5.14 0.52 
Model 5 Age at menarche        (continuous,             n=88) 1.01 0.74-1.37 0.97   0.93 0.64-1.28 0.56 
 Model 6 Clinical BV diagnosis        (n=3) 0.89 0.10-8.22 0.92  1.75 0.31-16.75 0.73 
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Table 3. Crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for factors associated with C-section 
delivery (n=88). 
  Unadjusted   Adjusted* 
  OR 95% CI 
p-




 Perceived weight at menarche               
Model 7 overweight or markedly     overweight                         (n=16) REF       REF     
  normal or underweight      (n=17) 0.97 0.24-3.91 0.97   1.56 0.39-5.42 0.72 
  pH             
 Model 8 4.0-4.5                    (n=61) REF       REF     
  >4.5                        (n=24) 1.70 0.54-5.35 0.36   1.71 0.22-6.27 0.45 









CHAPTER IV: DISCUSSION  
In this sample of 88 reproductive-age women, we found evidence to suggest that a 
woman’s vaginal microbiota in adulthood is associated with her mode of birth history. 
Specifically, women whose vaginal microbiota was characterized as the low-
Lactobacillus CST IV had a statistically significant 3-fold increase in the odds of being 
born via C-section. This indicates that women born by C-section were more likely to 
have a vaginal state characterized by higher proportions of BV-associated bacteria and 
higher likelihood for vaginal dysbiosis in adulthood [67]. BV remains a condition that is 
highly recurrent, associated with a number of adverse reproductive health outcomes and 
treatment and prevention remains remarkably ineffective [68]. This birth mode research 
may represent a potentially modifiable risk factor. Broadly, interventions may include 
reducing C-section rates, reseeding the infant girl microbiome with direct transfer from 
the mother, or probiotic cocktails administered at various phases of childhood. If such 
interventions have an effect on BV and vaginal dysbiosis, we will then have conclusive 
evidence on the causal link between the two. 
We anticipated that race would be a confounding factor in the model, as literature 
suggests it is highly associated with both birth mode and CST outcomes. However, we 
found that race was not significantly associated with birth mode in this relatively small 
study. Furthermore, adjusting for race did not change the OR in Model 1 by 10% or 
more, leading us to drop the variable as a potential confounder. We also considered the 
confounding effect of several factors that encompass socioeconomic status (SES). Studies 
have shown that the chance of women undergoing C-section is associated with higher 
education, lower residential crowding, and pregnancy planning [69]. While education in 
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this study was only moderately associated with birth mode (p=0.15), it produced a 
significant confounding effect (14.5% change in OR). As 17% of participants chose not 
to respond to education questions at the enrollment visit, it was not a variable that could 
reliably be included in the model. Finally, douching behavior was moderately associated 
with birth mode (p=.08) but resulted in small confounding effect (5% change in ORs). 
Women with a BV diagnosis were more likely to have a CST III or IV vaginal 
microbiota. However, BV was not specifically found to be associated with birth mode, as 
there were very few self- or clinician-reported cases of BV in the population (n=6). Half 
of these cases were self-reported, and self-reported BV is very unreliable, particularly 
since the condition can be asymptomatic. Since there were only three clinician-reported 
BV events at the enrollment visit, it was not possible to conduct further analysis on this 
variable. Of the women who had a recent BV diagnosis, only two were CST IV-B. The 
remaining four represented CST I and III-B. 
We were unable to conclusively demonstrate effect modification due to race in 
our study, perhaps due to small sample size and limited power. However, it was clear 
through stratified regression modelling that AAH women born via C-section were far 
more likely to be CST IV compared to non-AAH women born similarly, a finding that 
reaffirms our hypothesis derived from previous research [18].  
Age at menarche was not associated with a particular CST or birth mode. In 
addition, age and weight status at menarche did not produce a confounding effect greater 
than 10% on the relationship between CST and birth mode. This indicates that a woman’s 
age or weight status at menarche did not distort the strong relationship between CST and 
birth mode in our population. 
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In summary, this study found significant 3-fold association between low-
Lactobacillus microbial community state and being born via C-section, which indicates 
that C-section delivery may be related to vaginal dysbiosis in adulthood. Of the 
covariates we analyzed, factors of puberty were not shown to alter the strength of the 
relationship between adulthood CST and birth mode. Although AAH who were CST IV 
were more likely to have a history of C-section birth, race/ethnicity was not found to be 
an effect modifier. Although this study does not establish causality or characterize the 
long-term composition of the vaginal microbiota, results suggest that birth mode 
potentially impacts vaginal seeding and long-term disease outcomes. 
 
STRENGTHS AND LIMITATIONS 
CST was determined from one vaginal sample for each woman collected at the 
Parent study baseline visit. However, the vaginal microbiome is dynamic for many 
women and can change at various points in the menstrual cycle. Basing the overall CST 
assignment on one sampling day may result in misclassification. Given the rapid 
fluctuations in vaginal microbiota for many women, a cross-sectional study is limited in 
its ability to make conclusions about the composition and stability of the vaginal 
microbiota. The HCL dataset is longitudinal, with multiple samples taken over each 
participant’s enrollment. A future related study can develop a “community class” that 
assess overall CST profile of each woman over many sampling days. In addition, Jensen-
Shannon distances between all pairs of samples can assess the stability of the microbiota 
longitudinally. While the microbiota can be dynamic, longitudinal studies have also 
demonstrated that women tend to stay in the same plane of fluctuation over many months 
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and years of observation [40]. Women who are found in CST IV tend to fluctuate 
between IV and the L. iners-dominated CST III most often [70]. In addition, from an 
epidemiologic perspective, if there were non-differential misclassification of CSTs, that 
would serve to dampen the point estimates toward the null. That we found women with 
CST IV microbiotas had 3-fold statistically significant increased odds for C-section 
history indicates the association between birth mode and CST may be even more 
pronounced if we had more temporal observation points.  
For two participants, vaginal sample reads from the baseline were replaced by a 
follow-up sample taken two days later due to low bacterial reads in the baseline sample. 
In both of these cases, it was clear that the baseline read was an aberration, and the 
microbiota classification for subsequent sample days remained very consistent. However, 
we did not measure the consistency of all participants’ microbiota composition in this 
analysis.  
Although the survey was very short, the questions themselves may be affected by 
recall bias. Surprisingly, most women seemed very sure about their own modes of birth. 
Several participants remarked that their mothers had told them the stories of their own 
birth many times and were fully aware of their status. The question on age at menarche 
caused more women to pause. Many were initially unsure of the exact age and pointed to 
a year in school (e.g., early in the fifth grade) in order to deduce their response. 
Participants were given the opportunity to reach out to their mothers or other family 
members to confirm their answers. Three women took this opportunity to confirm their 
age at menarche with a family member. All three of these women returned contact with 
us, and only one changed an answer she had previously given. It is still likely that these 
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birth and early-life factors will be reported with some error, given that the recall is many 
years later. In addition, self-characterization of childhood weight status is subjective. It 
appears that within this sample of young women, self-report of mode of birth was 
reliable; however, age at menarche and body mass in childhood was more difficult for 
adults to self-report.  
A strength of this study is that we were able to recruit a sufficient number of 
women born via C-section. The proportion of the women born via C-section in the study 
(18%) reflects the estimated rates of C-section deliveries when the young adult 
participants were born. Between 1975 and 1990, the percentage of C-section deliveries in 
the United States rose from 10.4% to 24.5% [71]. In the past three decades, the effect of 
C-section on the infant microbiota has incurred greater scrutiny due to the increased rate 
of cesarean deliveries worldwide and their potential association with disease, making this 
research timely.  
The study population was diverse, with women representing many race/ethnic 
groups, age groups, and other demographic categories. The HCL study aimed to recruit 
diverse participants in order to maximize generalizability of results. However, many of 
the women were students and employees at Johns Hopkins and other local universities, 
and consequently, the population was highly educated. The vast majority (89%) had some 
post-high school education with 47% having earned a bachelor’s degree or higher. In 
contrast, 30% of Baltimore city residents over age 25 had a bachelor’s degree or higher, 
according to 2011-2015 Census figures [72]. We also found that the study participants 
had a moderately high income status, with 26% reporting monthly earnings more than 
$3000. Although the group was highly educated, many women were between 17 and 23 
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years old, potentially explaining why the observed income status was not higher. Greater 
education in the population may improve access to care and decrease potential for BV.    
 Overall, the study design to re-contact HCL participants was successful, and we 
were able to reengage over 72% of the women who consented to be contacted for future 
research.  Re-contacting participants took several weeks to complete. Many participant 
phone numbers and email addresses had been disconnected in the time since their 
involvement with HCL. However, many former participants who we were able to contact 
seemed enthusiastic to take part in the follow-up research. Self-selection bias was a minor 
concern, as women who participated in multiple follow-ups for the parent study have 
proven to be very motivated and may be different from women who refused to 
participate. The $10 check incentive was an important factor in encouraging women to 
participate in the survey. After the call several women expressed interested in seeing 
published results of the HCL study as well as participating in research in the future.  
 
AREAS FOR FUTURE RESEARCH 
We aim to include more diverse groups of women to participate in this birth mode 
research to increase power and potentially improve the generalizability of our results. Our 
research group has identified another concluded study with hundreds of women already 
enrolled who we could re-contact to answer the birth mode survey. Vaginal samples have 
already been collected and characterized at IGS. However, similar limitations still persist. 
This cross-sectional study does not allow for characterization of the microbiome over the 
life span, although it would be exceptionally costly to follow baby girls from birth to 
adulthood in a longitudinal study.  
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Future research into the effect of birth mode should also collect data on whether 
the C-section was an elective or emergency procedure. The reasons why C-section 
deliveries are performed vary by the complications of pregnancy or delivery that 
preceded the cesarean. It is possible that these underlying causes are more important than 
the C-section event itself in determining bacterial transfer between mother and neonate. 
When doctors recommend emergent C-section, it is often accompanied by the varying 
use of medications, including antibiotics and anti-inflammatory pain analgesics, which 
can have independent effects on the microbiome of mother and neonate. In addition, if 
the mother is experiencing obstetric distress at the time of pregnancy, the underlying 
cause could influence her microbiome and transmission to the neonate. For example, a 
mother’s BV at birth is associated with adverse neonatal outcomes [73]. The effects of 
these birth factors are not well known, and therefore, it is important to note these factors 
in determining the protectiveness of either birth mode.  
In addition, future researchers could analyze the enduring effects of interventions 
to seed babies who are delivered by C-section. This is a controversial intervention, and its 
long-term effects are not well understood. An ongoing clinical trial by Dominguez-Bello 
et al. (ClinicalTrials.gov Identifier: NCT02407184) seeks to understand whether the 
microbiota of infants born via scheduled C-section can potentially be restored via seeding 
when assessed at one year [74]. Our adulthood microbiota data, as well as studies 
assessing adolescent outcomes, may encourage researchers to schedule follow-ups as the 
infant ages and establish the first long-term studies on the effect of birth mode and human 
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APPENDIX B: ORAL CONSENT SCRIPT 
 
Date: January 30, 2017 
Principal Investigator: Rebecca Brotman, PhD 
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ORAL CONSENT SCRIPT 
 




Hello, my name is Christina Stennett, and I am a graduate student at the University of 
Maryland. I am conducting a research study with women who participated in the Johns 
Hopkins Hormonal Contraceptive Longitudinal Study to understand how your mode of 
birth (whether by C-section or vaginal delivery) may affect your gynecologic health as an 
adult. As a former HCL Study participant, you are being asked to take part in this 
research study.   
 
If you agree to participate, I will ask you questions about your birth and childhood. This 
will take less than 10 minutes of your time. We appreciate you taking the time to 
participate in this study and understand your time is precious. Therefore, we you will 
receive a $10 check as a token of our appreciation for your participation.  
We will minimize any losses to confidentiality or privacy due to your participation. Your 
responses will be kept confidential and will be stored in password-protected computers 
and files. Your answers will be grouped with information from other participants in any 
published manuscripts. 
 
There is no direct benefit to you from participating. However, the findings will help 
researchers better understand how birth and early childhood factors affect vaginal health 
in adulthood.  
 
You do not have to agree to be in this study. If you join the study, you can change your 
mind later. You can decide not to take part or you can quit at any time. There will be no 
penalty or loss of any benefits if you decide to quit the study. If you do not want to join 
the study, it will not affect your care at Johns Hopkins. You can choose not to answer 
individual questions, and if at any time you decide you do not wish to participate any 
further, you can decline further participation. 
 
If you have any questions about your rights as a research participant, or if you think you 
have not been treated fairly, you may call the following Institutional Review Board (IRB) 
offices: 
• University of Maryland College Park IRB Board Office at (301) 405-0678 




People at Johns Hopkins who are involved in the study or who need to make sure the study 
is being done correctly will see the information.  In addition, people at Johns Hopkins may 
need to send your information to people outside of Johns Hopkins (for example, 
government groups like the Food and Drug Administration) who need to make sure the 
study is being done correctly. These people will use your information for the purpose of 
the study. 
 
We will continue to collect information about you until the end of the study unless you tell 
us that you have changed your mind. If you change your mind and don’t want your 
information used for the study anymore, you can call IRB offices of University of Maryland 
College Park or Johns Hopkins University.  Just remember, if we have already used your 
information for the study, the use of that information cannot be cancelled.  
 
We try to make sure that everyone who needs to see your information uses it only for the 
study and keeps it confidential - but, we cannot guarantee this. 
    
Do you have questions about the study?  
 
If you agree to participate in this research, please say “I consent.” 
 





APPENDIX C: TELEPHONE QUESTIONNAIRE  
Thank you for taking part in this study! The questionnaire is only 3 items long. Note that 
these questions are about your own birth and childhood (NOT your kids’). If you don’t 
know or are unsure of any of the answers, please tell me. 
 
A. Were you born via vaginal delivery or Cesarean section (C-section)? 
 Vaginal 
 C-section  
 I don’t know   
[Please feel free to contact your mother, other family members, or friends 
of your family to confirm.] 
 Prefer not to answer   
B. How old were you at your first menstrual period?  
 Age: ______________________ (Record exact age or range given.) 
 I don’t know   
[Please feel free to contact your mother, other family members, or friends 
of your family to confirm.] 
 Prefer not to answer   
C. How would you classify your own weight at the time of your first menstrual period 
(around age 10-13)? 
 Markedly underweight 
 Underweight  
 Average 
 Overweight  
 Markedly overweight 
 I don’t know   
[Please feel free to contact your mother, other family members, or friends 
of your family to confirm.] 
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